Literature DB >> 31727827

Cellular RNA surveillance in health and disease.

Sandra L Wolin1, Lynne E Maquat2,3.   

Abstract

The numerous quality control pathways that target defective ribonucleic acids (RNAs) for degradation play key roles in shaping mammalian transcriptomes and preventing disease. These pathways monitor most steps in the biogenesis of both noncoding RNAs (ncRNAs) and protein-coding messenger RNAs (mRNAs), degrading ncRNAs that fail to form functional complexes with one or more proteins and eliminating mRNAs that encode abnormal, potentially toxic proteins. Mutations in components of diverse RNA surveillance pathways manifest as disease. Some mutations are characterized by increased interferon production, suggesting that a major role of these pathways is to prevent aberrant cellular RNAs from being recognized as "non-self." Other mutations are common in cancer, or result in developmental defects, revealing the importance of RNA surveillance to cell and organismal function.
Copyright © 2019 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31727827      PMCID: PMC6938259          DOI: 10.1126/science.aax2957

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  49 in total

1.  Germline mutations in DIS3L2 cause the Perlman syndrome of overgrowth and Wilms tumor susceptibility.

Authors:  Dewi Astuti; Mark R Morris; Wendy N Cooper; Raymond H J Staals; Naomi C Wake; Graham A Fews; Harmeet Gill; Dean Gentle; Salwati Shuib; Christopher J Ricketts; Trevor Cole; Anthonie J van Essen; Richard A van Lingen; Giovanni Neri; John M Opitz; Patrick Rump; Irene Stolte-Dijkstra; Ferenc Müller; Ger J M Pruijn; Farida Latif; Eamonn R Maher
Journal:  Nat Genet       Date:  2012-02-05       Impact factor: 38.330

Review 2.  The exon junction complex as a node of post-transcriptional networks.

Authors:  Hervé Le Hir; Jérôme Saulière; Zhen Wang
Journal:  Nat Rev Mol Cell Biol       Date:  2015-12-16       Impact factor: 94.444

3.  ADAR1: A New Target for Immuno-oncology Therapy.

Authors:  Amruta Bhate; Tao Sun; Jin Billy Li
Journal:  Mol Cell       Date:  2019-03-07       Impact factor: 17.970

Review 4.  An RNA toolbox for cancer immunotherapy.

Authors:  Fernando Pastor; Pedro Berraondo; Iñaki Etxeberria; Josh Frederick; Ugur Sahin; Eli Gilboa; Ignacio Melero
Journal:  Nat Rev Drug Discov       Date:  2018-09-07       Impact factor: 84.694

5.  PKR Senses Nuclear and Mitochondrial Signals by Interacting with Endogenous Double-Stranded RNAs.

Authors:  Yoosik Kim; Joha Park; Sujin Kim; MinA Kim; Myeong-Gyun Kang; Chulhwan Kwak; Minjeong Kang; Baekgyu Kim; Hyun-Woo Rhee; V Narry Kim
Journal:  Mol Cell       Date:  2018-08-30       Impact factor: 17.970

6.  Helicase-Dependent RNA Decay Illuminated by a Cryo-EM Structure of a Human Nuclear RNA Exosome-MTR4 Complex.

Authors:  Eva-Maria Weick; M Rhyan Puno; Kurt Januszyk; John C Zinder; Michael A DiMattia; Christopher D Lima
Journal:  Cell       Date:  2018-06-14       Impact factor: 41.582

Review 7.  Noncoding RNA Surveillance: The Ends Justify the Means.

Authors:  Cedric Belair; Soyeong Sim; Sandra L Wolin
Journal:  Chem Rev       Date:  2017-10-12       Impact factor: 60.622

8.  Multiple myeloma-associated hDIS3 mutations cause perturbations in cellular RNA metabolism and suggest hDIS3 PIN domain as a potential drug target.

Authors:  Rafal Tomecki; Karolina Drazkowska; Iwo Kucinski; Krystian Stodus; Roman J Szczesny; Jakub Gruchota; Ewelina P Owczarek; Katarzyna Kalisiak; Andrzej Dziembowski
Journal:  Nucleic Acids Res       Date:  2013-10-22       Impact factor: 16.971

9.  A retrovirus packages nascent host noncoding RNAs from a novel surveillance pathway.

Authors:  Matthew J Eckwahl; Soyeong Sim; Derek Smith; Alice Telesnitsky; Sandra L Wolin
Journal:  Genes Dev       Date:  2015-03-15       Impact factor: 11.361

Review 10.  Targeting RNA for processing or destruction by the eukaryotic RNA exosome and its cofactors.

Authors:  John C Zinder; Christopher D Lima
Journal:  Genes Dev       Date:  2017-01-15       Impact factor: 11.361

View more
  37 in total

1.  Splice variants of lncRNA RNA ANRIL exert opposing effects on endothelial cell activities associated with coronary artery disease.

Authors:  Hyosuk Cho; Yabo Li; Stephen Archacki; Fan Wang; Gang Yu; Susmita Chakrabarti; Yang Guo; Qiuyun Chen; Qing Kenneth Wang
Journal:  RNA Biol       Date:  2020-06-30       Impact factor: 4.652

2.  Nucleocytoplasmic Proteomic Analysis Uncovers eRF1 and Nonsense-Mediated Decay as Modifiers of ALS/FTD C9orf72 Toxicity.

Authors:  Juan A Ortega; Elizabeth L Daley; Sukhleen Kour; Marisa Samani; Liana Tellez; Haley S Smith; Elizabeth A Hall; Y Taylan Esengul; Yung-Hsu Tsai; Tania F Gendron; Christopher J Donnelly; Teepu Siddique; Jeffrey N Savas; Udai B Pandey; Evangelos Kiskinis
Journal:  Neuron       Date:  2020-02-13       Impact factor: 17.173

Review 3.  Nonsense suppression therapies in human genetic diseases.

Authors:  Patrícia Martins-Dias; Luísa Romão
Journal:  Cell Mol Life Sci       Date:  2021-03-22       Impact factor: 9.261

4.  The nuclear and cytoplasmic activities of RNA polymerase III, and an evolving transcriptome for surveillance.

Authors:  Alan C Kessler; Richard J Maraia
Journal:  Nucleic Acids Res       Date:  2021-12-02       Impact factor: 16.971

5.  The leucine-NH4+ uptake regulator Any1 limits growth as part of a general amino acid control response to loss of La protein by fission yeast.

Authors:  Vera Cherkasova; James R Iben; Kevin J Pridham; Alan C Kessler; Richard J Maraia
Journal:  PLoS One       Date:  2021-06-21       Impact factor: 3.240

Review 6.  NCBP3: A Multifaceted Adaptive Regulator of Gene Expression.

Authors:  Xavier Rambout; Lynne E Maquat
Journal:  Trends Biochem Sci       Date:  2020-10-05       Impact factor: 13.807

7.  Post-transcriptional regulation by the exosome complex is required for cell survival and forebrain development via repression of P53 signaling.

Authors:  Pauline Antonie Ulmke; Yuanbin Xie; Godwin Sokpor; Linh Pham; Orr Shomroni; Tea Berulava; Joachim Rosenbusch; Uttiya Basu; Andre Fischer; Huu Phuc Nguyen; Jochen F Staiger; Tran Tuoc
Journal:  Development       Date:  2021-02-08       Impact factor: 6.868

Review 8.  Epigenetic Alterations in the Gastrointestinal Tract: Current and Emerging Use for Biomarkers of Cancer.

Authors:  William M Grady; Ming Yu; Sanford D Markowitz
Journal:  Gastroenterology       Date:  2020-12-03       Impact factor: 22.682

9.  Recruitment of Xrn1 to stress-induced genes allows efficient transcription by controlling RNA polymerase II backtracking.

Authors:  José García-Martínez; María E Pérez-Martínez; José E Pérez-Ortín; Paula Alepuz
Journal:  RNA Biol       Date:  2020-12-15       Impact factor: 4.652

10.  In vivo 5-ethynyluridine (EU) labelling detects reduced transcription in Purkinje cell degeneration mouse mutants, but can itself induce neurodegeneration.

Authors:  Lisanne J Van't Sant; Joshua J White; Jan H J Hoeijmakers; Wilbert P Vermeij; Dick Jaarsma
Journal:  Acta Neuropathol Commun       Date:  2021-05-21       Impact factor: 7.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.